Mauro Di Ianni

16PUBLICATIONS
47CO-AUTHORS
Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 29, 2026
Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia.

|Jul 16, 2026
CAR-T TEMRA and CAR-Tregs in vivo expansion are both associated with a poor response after CD19.CAR-T therapy.

|May 13, 2025
Cytomegalovirus infection after autologous transplantation in patients with multiple myeloma exposed to daratumumab.

Carmine Liberatore, Mario D'Uva, Annalisa Natale

|Feb 13, 2025
Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer.

Davide Brocco, Pasquale Simeone, Pietro Di Marino

|Feb 04, 2025
CD19.CAR T-cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy.

Paola Lanuti, Francesco Guardalupi, Giulia Corradi

|May 25, 2024
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses.

Anna Piro, Maria Concetta Cufaro, Paola Lanuti

Pageof 3

Frequent Collaborators

4 joint publications

Alessandro Cama

4 joint publications

Rosalba Florio

4 joint publications

Paola Lanuti

4 joint publications

Davide Brocco